Taub Rebecca 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Madrigal (MDGL) Director Rebecca Taub Sells 491 Shares
What Happened
- Rebecca Taub, a director of Madrigal Pharmaceuticals (MDGL), reported the sale of 491 shares on March 6, 2026. The shares were disposed at $431.94 per share for a total value of approximately $212,083.
- This was a sale (not a purchase); per the filing the sale was automatic to cover tax withholding on vested restricted stock units rather than an individual trading decision.
Key Details
- Transaction date and price: 2026-03-06 — 491 shares at $431.94 each.
- Total proceeds: ~$212,083.
- Shares owned after transaction: Not specified in this filing.
- Footnotes: F1 — sale made by the issuer on the reporting person’s behalf to cover tax withholding (automatic, not at the Reporting Person’s discretion). F2 — Reporting Person and spouse are managing members of SQN, LLC; Reporting Person disclaims beneficial ownership except to extent of pecuniary interest.
- Timeliness: Filing covers the transaction date 2026-03-06 and was filed on the same date (no late filing indicated).
Context
- The filing indicates a routine sell-to-cover for tax withholding related to RSU vesting, which is a common administrative transaction and does not necessarily signal the insider’s view of the company.
Insider Transaction Report
Form 4
Taub Rebecca
Director
Transactions
- Sale
Common Stock
[F1]2026-03-06$431.94/sh−491$212,083→ 452,213 total
Holdings
- 655,540(indirect: By LLC)
Common Stock
[F2]
Footnotes (2)
- [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- [F2]The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-03-06